Jane Street Group, LLC Seres Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$2.7 - $7.62 $38,070 - $107,442	-14,100 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$6.3 - $8.84 $410,130 - $575,484	-65,100 Reduced 82.2%	14,100 $100,000
Q4 2021 Feb 15, 2022	BUY	$6.02 - $11.43 $176,386 - $334,899	29,300 Added 58.72%	79,200 $660,000
Q3 2021 Nov 16, 2021	SELL	$5.46 - $22.6 $521,976 - $2.16 Million	-95,600 Reduced 65.7%	49,900 $347,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $173,524 - $228,984	9,400 Added 6.91%	145,500 $3.47 Million
Q1 2021 May 18, 2021	BUY	$17.66 - $28.92 $1.05 Million - $1.71 Million	59,200 Added 76.98%	136,100 $2.8 Million
Q4 2020 Feb 17, 2021	BUY	$23.25 - $37.73 $378,975 - $614,999	16,300 Added 26.9%	76,900 $1.88 Million
Q3 2020 Nov 17, 2020	BUY	$3.74 - $28.74 $226,644 - $1.74 Million	60,600 New	60,600 $1.72 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $110M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.